Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study

NCT01946919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18260

Last updated 2022-07-27

No results posted yet for this study

Summary

Cinepazide Maleate Injection is widely used in cerebrovascular disease in china. The safety of the cinepazide, especially the blood system, has not been fully evaluated in Chinese population. In order to improve the rational use of cinepazide, the investigators observe its clinical use in the real world in China, evaluate its safety and clinical benefit in a large Chinese population.

Conditions

  • Adverse Drug Reaction
  • Cinepazide
  • Stroke

Sponsors & Collaborators

  • Beijing Sihuan Pharmaceutical Co. Ltd.

    collaborator INDUSTRY
  • Beijing Shijitan Hospital,the 9th Clinical Medical College of Peking university

    collaborator UNKNOWN
  • China Rehabilitation Research Center

    collaborator OTHER_GOV
  • Hua Xin Hospital First Hospital of Tsing Hua University

    collaborator UNKNOWN
  • Fu Xing Hospital, Capital Medical University

    collaborator OTHER
  • Beijing Chuiyangliu Hospital(Beijing Minimally Invasive Hospital)

    collaborator UNKNOWN
  • Dongfang Hospital Beijing University of Chinese Medicine

    collaborator OTHER
  • Dongzhimen Hospital, Beijing

    collaborator OTHER
  • Xuanwu Hospital, Beijing

    collaborator OTHER
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    collaborator OTHER
  • Southern Medical University, China

    collaborator OTHER
  • Guangzhou First People's Hospital

    collaborator OTHER
  • Panyu Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Second Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • The People's Hospital of Gaozhou

    collaborator OTHER
  • Zhongshan Hospital Of Traditional Chinese Medicine

    collaborator OTHER
  • Second Affiliated Hospital of Shantou University Medical College

    collaborator OTHER
  • Sun Yat-sen University

    collaborator OTHER
  • Central People's Hospital of Zhanjiang

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Tongji Hospital

    collaborator OTHER
  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • People's Hospital of Dongxihu District

    collaborator UNKNOWN
  • Shenlong Hospital

    collaborator UNKNOWN
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Central South University

    collaborator OTHER
  • The Third Xiangya Hospital of Central South University

    collaborator OTHER
  • Hunan Provincial People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

    collaborator OTHER
  • The Third Hospital of Changsha

    collaborator UNKNOWN
  • Ankang City Central Hospital

    collaborator OTHER
  • San Er Ling Yi Hospital

    collaborator UNKNOWN
  • Xijing Hospital

    collaborator OTHER
  • Tang-Du Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Gansu Provincial Hospital

    collaborator OTHER
  • Xi'an Central Hospital

    collaborator OTHER
  • LanZhou University

    collaborator OTHER
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • Binzhou People's Hospital

    collaborator OTHER
  • Jiangxi Provincial People's Hopital

    collaborator OTHER
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Second Affiliated Hospital of Nanchang University

    collaborator OTHER
  • The Third Affiliated Hospital of Nanchang University

    collaborator OTHER
  • The Third Hospital of Nanchang

    collaborator UNKNOWN
  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • First Affiliated Hospital of Heilongjiang Chinese Medicine University

    collaborator OTHER
  • People's Hospital of Heilongjiang Province

    collaborator UNKNOWN
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • The first hospital of Harbin City

    collaborator UNKNOWN
  • The Fourth Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Second Affiliated Hospital of Heilongjiang University of Chinese Medicine

    collaborator OTHER
  • First Hospital of China Medical University

    collaborator OTHER
  • People's Liberation Army No.202 Hospital

    collaborator OTHER
  • The Fourth Affiliated Hospital of China Medical University

    collaborator OTHER
  • General Hospital of Shenyang Military Region

    collaborator OTHER
  • The four six three hospital of people's Liberation Army

    collaborator UNKNOWN
  • First People's Hospital of Shenyang

    collaborator OTHER
  • Jilin Province People's Hospital

    collaborator UNKNOWN
  • Beihua University

    collaborator OTHER
  • Shenzhou Hospital to Shenyang Medical College

    collaborator UNKNOWN
  • Peking University Third Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2021-12-31
Completion
2022-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01946919 on ClinicalTrials.gov